Articles related to EMERGING THERAPIES

AMPA Receptor Modulation Shows Promise in Major Depressive Disorder Treatment

“These findings support AMPA receptors as a clinically relevant treatment target in MDD.” – Samantha Yohn, PhD, Neurocrine Biosciences, Psych Congress NP Institute, 2026

Psychiatry April 1st 2026

Tags: DEPRESSION EMERGING THERAPIES

Cleveland Clinic Journal of Medicine (CCJM)

Lipoprotein(a) in Clinical Practice: What Clinicians Need to Know

“Pelacarsen lowered lipoprotein(a) to less than 50 mg/dL in 98% of participants, but levels rebounded after 16 weeks.”

Cardiology December 3rd 2025

Tags: EMERGING THERAPIES LIPID MANAGEMENT PREVENTIVE MEDICINE

News Medical

Potential Health Benefits of Methylene Blue

Methylene blue’s ability to penetrate the blood-brain barrier while reducing oxidative stress and promoting Nrf2 expression presents a novel therapeutic pathway for neurodegenerative disorders that warrants further investigation despite limited clinical evidence.

Emergency Medicine April 30th 2025

Tags: CRITICAL CARE EMERGING THERAPIES PHARMACOLOGY REVIEW

<< 1 2 … 4 5

Trending Topics:

Articles related to EMERGING THERAPIES

AMPA Receptor Modulation Shows Promise in Major Depressive Disorder Treatment

Lipoprotein(a) in Clinical Practice: What Clinicians Need to Know

Potential Health Benefits of Methylene Blue

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form